Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.

Maria C Azevedo CoutinhoNuno Cortez-DiasGuilhermina CantinhoSusana GonçalvesNelson CunhaTiago RodriguesLaura SantosIsabel ConceiçãoJoão AgostinhoFausto J Pinto

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2023)

DPD scintigraphy is useful for prognostic stratification of ATTR V30M mutation carriers. Patients without septal thickening and no DPD uptake present the best prognosis compared to those with any signs of cardiac involvement.

Keyphrases

end stage renal disease
left ventricular
chronic kidney disease
newly diagnosed
ejection fraction
pet ct
prognostic factors
heart failure
patient reported outcomes
multiple myeloma